Cidara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 1.09 M | $23.54 M | 0.00% | 7.71% |
| VR ADVISER, LLC | 05/15/2025 | 1.05 M | $22.65 M | 37.32% | 7.42% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 1.01 M | $21.67 M | 0.00% | 7.09% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 990.00 K | $21.32 M | 167.60% | 6.98% |
| BVF INC/IL | 05/15/2025 | 924.64 K | $19.92 M | -15.39% | 6.52% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 703.08 K | $15.14 M | 0.00% | 4.96% |
| VIVO CAPITAL, LLC | 05/12/2025 | 684.28 K | $14.74 M | 2.04% | 4.83% |
| VANGUARD GROUP INC | 05/09/2025 | 509.58 K | $10.98 M | 134.28% | 3.59% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 504.54 K | $10.87 M | 100.00% | 3.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 342.48 K | $7.38 M | 703.50% | 2.42% |
| CITADEL ADVISORS LLC | 05/15/2025 | 287.78 K | $6.20 M | 100.00% | 2.03% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 248.94 K | $5.36 M | 361.51% | 1.76% |
| ACUTA CAPITAL PARTNERS, LLC | 05/15/2025 | 125.71 K | $2.71 M | 130.77% | 0.89% |
| ABRDN PLC | 05/13/2025 | 120.88 K | $2.60 M | 100.00% | 0.85% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 113.86 K | $2.45 M | 1,751.90% | 0.80% |
| CHECKPOINT CAPITAL L.P. | 05/15/2025 | 104.38 K | $2.25 M | -47.00% | 0.74% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 92.52 K | $1.99 M | -3.24% | 0.65% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 79.08 K | $1.70 M | 406.90% | 0.56% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 63.58 K | $1.37 M | 76.81% | 0.45% |
| 5AM VENTURE MANAGEMENT, LLC | 05/15/2025 | 56.73 K | $1.22 B | 0.00% | 0.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 54.98 K | $1.18 M | 3.61% | 0.39% |
| BLACKROCK, INC. | 05/02/2025 | 52.90 K | $1.14 M | -4.73% | 0.37% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 42.14 K | $907.76 K | 203.84% | 0.30% |
| NORTHERN TRUST CORP | 05/13/2025 | 33.56 K | $722.88 K | -1.17% | 0.24% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 27.50 K | $592.37 K | 54,902.00% | 0.19% |
| STATE STREET CORP | 05/15/2025 | 22.58 K | $486.29 K | 18.35% | 0.16% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 21.12 K | $455.01 K | -57.37% | 0.15% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 20.94 K | $451.01 K | -16.04% | 0.15% |
| OMERS ADMINISTRATION CORP | 05/14/2025 | 19.30 K | $415.72 K | 53.17% | 0.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 17.13 K | $368.94 K | 100.00% | 0.12% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 05/14/2025 | 14.31 K | $308.26 K | 0.00% | 0.10% |
| WEST MICHIGAN ADVISORS, LLC | 05/09/2025 | 13.50 K | $290.79 K | 100.00% | 0.10% |
| AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 10.41 K | $224.21 K | 100.00% | 0.07% |
| MORGAN STANLEY | 05/15/2025 | 8.22 K | $176.99 K | 238.15% | 0.06% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 1.55 K | $33.44 K | -25.56% | 0.01% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.20 K | $25.85 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 933 | $20.10 K | 100.00% | 0.01% |
| CITIGROUP INC | 05/12/2025 | 577 | $12.43 K | -92.39% | 0.00% |
| POINT72 (DIFC) LTD | 05/15/2025 | 469 | $10.10 K | 136.87% | 0.00% |
| AVION WEALTH | 05/09/2025 | 250 | $6.00 K | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 04/30/2025 | 40 | $860 | 0.00% | 0.00% |
| BARCLAYS PLC | 05/15/2025 | 28 | $1.00 K | 100.00% | 0.00% |
| 05/02/2025 | 20 | $431 | 0.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 17 | $366 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 6 | $129 | 0.00% | 0.00% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
| STEMPOINT CAPITAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cidara Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 56 institutional investors and hedge funds held shares of Cidara Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 1.09 M
VR Adviser, LLC: 1.05 M
TCG Crossover Management, LLC: 1.01 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 990,000
BVF INC/IL: 924,642
Bain Capital Life Sciences Investors, LLC: 703,080
67.43% of Cidara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.71 M shares in the last 24 months. This purchase volume represents approximately $297.19 M in transactions.